Digital biomarkers Soundable Health offers AI-driven acoustic biomarkers that can monitor a range of health conditions using everyday sounds. This presents a sales opportunity to partner with healthcare providers and payers seeking noninvasive, smartphone-based monitoring solutions to improve chronic disease management and reduce in-person visits.

Chronic care focus The company targets underserved chronic symptoms such as BPH in urology and respiratory cough symptoms, signaling a niche with high unmet needs. Potential sales conversations can emphasize symptom tracking, early detection, and remote monitoring to support telemedicine platforms and specialty clinics.

AI model launch Recent launch of proprietary AI models for analyzing acoustic signals indicates readiness for commercial deployments. Position this as a capability to accelerate decision support, triage, and outcome measurement within digital health ecosystems, including hospital IT, EHR integrations, and mobile health apps.

SMB to mid-market With 11-50 employees and revenue in the low single-digit millions, Soundable Health sits in a growth-ready segment. Target mid-market healthcare providers, clinics, and regional health networks seeking innovative, cost-effective remote monitoring solutions with scalable cloud infrastructure.

Strategic partnerships The company’s tech stack and mobile-friendly approach pair well with existing consumer and clinical digital health platforms. Explore partnerships with device manufacturers, telehealth platforms, and payer programs to expand reach, integration, and reimbursement pathways for audible biomarker solutions.